EA200600527A1 - Активирующее ppar соединение и содержащая его фармацевтическая композиция - Google Patents
Активирующее ppar соединение и содержащая его фармацевтическая композицияInfo
- Publication number
- EA200600527A1 EA200600527A1 EA200600527A EA200600527A EA200600527A1 EA 200600527 A1 EA200600527 A1 EA 200600527A1 EA 200600527 A EA200600527 A EA 200600527A EA 200600527 A EA200600527 A EA 200600527A EA 200600527 A1 EA200600527 A1 EA 200600527A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- atom
- alkyl
- hydrogen atom
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Abstract
Соединение, представленное следующей формулой (I):(где каждый из Rи R, которые могут быть одинаковыми или отличаются друг от друга, представляет собой атом водорода, метильную группу или этильную группу; каждый из R, R, Rи R, которые могут быть одинаковыми или отличаются друг от друга, представляет собой атом водорода, атом галогена, нитрогруппу, гидроксильную группу, Cалкильную группу, трифторметильную группу, Cалкоксильную группу, Cалкилкарбонилоксигруппу, ди-Салкиламиногруппу, Cалкилсульфонилоксигруппу, Cалкилсульфонильную группу, Cалкилсульфинильную группу или Cалкилтиогруппу, или Rи R, или Rи Rмогут быть связаны вместе с образованием алкилендиоксигруппы; Х представляет собой атом кислорода, атом серы или N-R(Rпредставляет собой атом водорода, Cалкильную группу, Cалкилсульфонильную группу или Cалкилоксикарбонильную группу); Y представляет собой атом кислорода, C(O)(1 представляет собой число от 0 до 2), карбонильную группу, карбониламиногруппу, аминокарбонильную группу, сульфониламиногруппу или аминосульфонильную группу; Z представляет собой СН или N; n представляет собой число от 1 до 6; и m представляет собой число от 2 до 6) или его соль; и терапевтические лекарственные средства, содержащие любое такое соединение или соль.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49935703P | 2003-09-03 | 2003-09-03 | |
JP2003317353 | 2003-09-09 | ||
JP2003364817 | 2003-10-24 | ||
PCT/JP2004/012750 WO2005023777A1 (ja) | 2003-09-03 | 2004-09-02 | Ppar活性化化合物及びこれを含有する医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200600527A1 true EA200600527A1 (ru) | 2006-08-25 |
EA009374B1 EA009374B1 (ru) | 2007-12-28 |
Family
ID=34279568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600527A EA009374B1 (ru) | 2003-09-03 | 2004-09-02 | Активирующее ppar соединение и содержащая его фармацевтическая композиция |
Country Status (18)
Country | Link |
---|---|
US (2) | US7109226B2 (ru) |
EP (1) | EP1661890B1 (ru) |
JP (2) | JP4226005B2 (ru) |
KR (1) | KR101160808B1 (ru) |
AU (1) | AU2004270538C1 (ru) |
BR (1) | BRPI0413991B8 (ru) |
CA (1) | CA2535749C (ru) |
CY (1) | CY1111867T1 (ru) |
EA (1) | EA009374B1 (ru) |
HK (1) | HK1093975A1 (ru) |
HR (1) | HRP20110009T1 (ru) |
IL (1) | IL173639A (ru) |
MX (1) | MXPA06002435A (ru) |
NO (1) | NO335823B1 (ru) |
NZ (1) | NZ545692A (ru) |
PL (1) | PL1661890T3 (ru) |
TW (1) | TWI324599B (ru) |
WO (1) | WO2005023777A1 (ru) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004111077A1 (en) * | 2003-06-18 | 2004-12-23 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor |
EP2316846B1 (en) * | 2003-07-31 | 2019-10-02 | Ocera Therapeutics, Inc. | Spatially-defined macrocyclic compounds useful for drug discovery |
US7398116B2 (en) | 2003-08-11 | 2008-07-08 | Veran Medical Technologies, Inc. | Methods, apparatuses, and systems useful in conducting image guided interventions |
US7301033B2 (en) * | 2005-01-27 | 2007-11-27 | Kowa Co., Ltd. | PPAR-activating compound |
PL1852426T3 (pl) | 2005-02-23 | 2014-04-30 | Kowa Co | Sposób wytwarzania optycznie czynnego związku aktywującego PPAR oraz związku pośredniego |
EP1854779A4 (en) * | 2005-03-01 | 2010-07-21 | Kowa Co | OPTICALLY ACTIVE, PPAR-ACTIVATING COMPOSITE INTERMEDIATE PRODUCT AND MANUFACTURING METHOD THEREFOR |
US7714141B2 (en) | 2005-05-31 | 2010-05-11 | Kowa Co., Ltd. | Processes for production of optically active PPAR-activating compounds and intermediates for production thereof |
EP1908747B1 (en) | 2005-07-28 | 2012-01-04 | Kowa Company, Ltd. | Process for producing optically active 2-hydroxybutyric ester |
US8088733B2 (en) * | 2006-07-06 | 2012-01-03 | Tranzyme Pharma Inc. | Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
US20100183696A1 (en) * | 2007-01-30 | 2010-07-22 | Allergan, Inc | Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists |
TWI407955B (zh) * | 2007-03-29 | 2013-09-11 | Kowa Co | 高脂血症之預防及/或治療劑 |
WO2011037223A1 (ja) * | 2009-09-28 | 2011-03-31 | 興和株式会社 | 内臓脂肪重量の低下剤 |
TWI425948B (zh) * | 2012-01-20 | 2014-02-11 | Compositions for the inhibition or killing of Porphyromonas gingivalis and their use for the alleviation or treatment of periodontal disease and other diseases | |
MX357446B (es) * | 2012-09-27 | 2018-07-10 | Kowa Co | Agente terapeutico para dislipidemia. |
CN105102415B (zh) | 2013-03-29 | 2017-03-15 | 兴和株式会社 | 2‑羟基羧酸或其衍生物的光学纯度提高法 |
TWI696462B (zh) | 2013-07-10 | 2020-06-21 | 日商興和股份有限公司 | 非酒精性脂肪性肝疾病治療劑 |
EP3939586A1 (en) | 2013-08-28 | 2022-01-19 | Kowa Company, Ltd. | Combination of pemafibrate and omega-3 fatty acids for dyslipedmia |
WO2015106164A1 (en) * | 2014-01-10 | 2015-07-16 | Rgenix, Inc. | Lxr agonists and uses thereof |
TW201618777A (zh) * | 2014-09-26 | 2016-06-01 | 興和股份有限公司 | 脂質異常症治療劑 |
TWI691331B (zh) * | 2014-09-26 | 2020-04-21 | 日商興和股份有限公司 | 脂質異常症治療劑 |
WO2017082393A1 (ja) * | 2015-11-12 | 2017-05-18 | 学校法人 聖マリアンナ医科大学 | 緑内障予防治療剤 |
ES2847168T5 (es) | 2016-07-29 | 2024-02-20 | Kowa Co | Métodos para prevenir acontecimientos cardiovasculares en poblaciones dislipidémicas de riesgo residual |
JP2019059673A (ja) * | 2016-08-25 | 2019-04-18 | 興和株式会社 | Pbcの治療剤 |
US20210069157A1 (en) | 2016-08-25 | 2021-03-11 | Kowa Company, Ltd. | Agent for treatment of pbc |
KR102487075B1 (ko) | 2017-01-11 | 2023-01-09 | 교와 가부시키가이샤 | 비알코올성 지방성 간 질환의 예방 및 치료약 |
US10314825B2 (en) | 2017-02-24 | 2019-06-11 | Kowa Company, Ltd. | Agent for treatment of PBC |
JP7425603B2 (ja) * | 2017-06-30 | 2024-01-31 | 興和株式会社 | 医薬組成物 |
US20200113873A1 (en) | 2017-06-30 | 2020-04-16 | Kowa Company, Ltd. | Medicament |
CN110809470A (zh) * | 2017-06-30 | 2020-02-18 | 兴和株式会社 | 医药品 |
KR102512518B1 (ko) | 2017-06-30 | 2023-03-21 | 교와 가부시키가이샤 | 페마피브레이트를 함유하는 의약 |
US11298340B2 (en) | 2017-06-30 | 2022-04-12 | Kowa Company, Ltd. | Pharmaceutical composition |
WO2019004447A1 (ja) * | 2017-06-30 | 2019-01-03 | 興和株式会社 | 医薬組成物 |
CN110809469A (zh) * | 2017-06-30 | 2020-02-18 | 兴和株式会社 | 医药组合物 |
EP3646867A4 (en) | 2017-06-30 | 2021-03-24 | Kowa Company, Ltd. | PHARMACEUTICAL COMPOSITION |
JP6959049B2 (ja) * | 2017-06-30 | 2021-11-02 | 興和株式会社 | 新規低アルブミン血症改善薬 |
US20200121648A1 (en) * | 2017-06-30 | 2020-04-23 | Kowa Company, Ltd. | Pharmaceutical composition |
EP3713575A4 (en) | 2017-11-21 | 2021-08-25 | Rgenix, Inc. | POLYMORPHS AND THEIR USES |
JP2021506907A (ja) * | 2017-12-21 | 2021-02-22 | 興和株式会社 | 高トリグリセライド血症の治療方法 |
US11446282B2 (en) | 2017-12-21 | 2022-09-20 | Kowa Company, Ltd. | Methods of treating mixed dyslipidemia and hypertriglycertdemia |
US11420945B2 (en) | 2017-12-27 | 2022-08-23 | Teva Pharmaceuticals International Gmbh | Solid state forms of Pemafibrate |
WO2019216313A1 (ja) | 2018-05-08 | 2019-11-14 | 国立大学法人岡山大学 | 心血管疾患に有用な医薬 |
JP7058762B2 (ja) * | 2018-12-27 | 2022-04-22 | 興和株式会社 | 医薬品 |
EP3903782A4 (en) | 2018-12-27 | 2022-10-05 | Kowa Company, Ltd. | PHARMACEUTICAL COMPOSITION |
TWI829841B (zh) * | 2018-12-27 | 2024-01-21 | 日商興和股份有限公司 | 醫藥品 |
CA3161274A1 (en) | 2019-12-13 | 2021-06-17 | Stephen Wald | Metal salts and uses thereof |
CA3215775A1 (en) | 2021-04-20 | 2022-10-27 | Noriyuki Inoue | Combination medicine for preventing/treating dyslipidemia or cardiovascular disease |
CN117222408A (zh) | 2021-04-28 | 2023-12-12 | 兴和株式会社 | 血液中肉碱增加剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6025425B2 (ja) * | 1975-03-06 | 1985-06-18 | 藤沢薬品工業株式会社 | 置換フエノキシ脂肪酸類の合成法 |
JPS593465B2 (ja) * | 1974-06-04 | 1984-01-24 | 藤沢薬品工業株式会社 | チカンアミノアルキルチカンフエノキシカルボンサンルイノ セイゾウホウ |
AU1856997A (en) | 1996-02-02 | 1997-08-22 | Merck & Co., Inc. | Method for raising hdl cholesterol levels |
JPWO2002046176A1 (ja) * | 2000-12-05 | 2004-04-08 | 日本ケミファ株式会社 | ペルオキシソーム増殖剤応答性受容体の活性化剤 |
DE10151390A1 (de) * | 2001-10-18 | 2003-05-08 | Bayer Ag | Essigsäurederivate |
WO2003074495A1 (en) * | 2002-03-01 | 2003-09-12 | Smithkline Beecham Corporation | Hppars activators |
US6653334B1 (en) * | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
-
2004
- 2004-09-02 MX MXPA06002435A patent/MXPA06002435A/es active IP Right Grant
- 2004-09-02 BR BRPI0413991A patent/BRPI0413991B8/pt not_active IP Right Cessation
- 2004-09-02 WO PCT/JP2004/012750 patent/WO2005023777A1/ja active Application Filing
- 2004-09-02 CA CA2535749A patent/CA2535749C/en not_active Expired - Fee Related
- 2004-09-02 KR KR1020067003950A patent/KR101160808B1/ko active IP Right Grant
- 2004-09-02 AU AU2004270538A patent/AU2004270538C1/en not_active Ceased
- 2004-09-02 PL PL04772699T patent/PL1661890T3/pl unknown
- 2004-09-02 JP JP2005513668A patent/JP4226005B2/ja active Active
- 2004-09-02 NZ NZ545692A patent/NZ545692A/xx unknown
- 2004-09-02 EP EP04772699A patent/EP1661890B1/en active Active
- 2004-09-02 EA EA200600527A patent/EA009374B1/ru not_active IP Right Cessation
- 2004-09-03 TW TW093126702A patent/TWI324599B/zh not_active IP Right Cessation
- 2004-09-03 US US10/933,467 patent/US7109226B2/en active Active
-
2006
- 2006-02-09 NO NO20060654A patent/NO335823B1/no not_active IP Right Cessation
- 2006-02-09 IL IL173639A patent/IL173639A/en active IP Right Grant
- 2006-04-20 US US11/407,076 patent/US7183295B2/en active Active
- 2006-12-29 HK HK06114278.8A patent/HK1093975A1/xx not_active IP Right Cessation
-
2008
- 2008-10-31 JP JP2008281020A patent/JP4931893B2/ja not_active Expired - Fee Related
-
2011
- 2011-01-07 HR HR20110009T patent/HRP20110009T1/hr unknown
- 2011-03-31 CY CY20111100343T patent/CY1111867T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200600527A1 (ru) | Активирующее ppar соединение и содержащая его фармацевтическая композиция | |
AR058403A1 (es) | PIRIMIDINILOXI Y PIRIDINILOXI UREAS SUSTITUíDAS COMO INHIBIDORES DE PROTEíNA QUINASAS, COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVIDAD BASAL DE B-RAF. | |
AR048641A1 (es) | Compuestos de aril- o heteroarilamida ortosustituidos utiles como antago-nistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicame | |
DK1258484T3 (da) | Nye isoxazol- og thiazolforbindelser og anvendelse deraf som lægemidler | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
EA200401613A1 (ru) | Лекарственное средство для лечения рака | |
AR044036A1 (es) | Compuestos de pirazolopirimidinas y pirazolopiridinas como ligandos de receptor cannabinoide, composiciones farmaceuticas y usos de los mismos | |
EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
CY1110355T1 (el) | Ενεργοποιητης του ενεργοποιουμενου απο πολλαπλασιαστη υπεροξυσωματων υποδοχεα δ | |
RS51451B (en) | PIRIDINE CARBOXAMIDES AS INHIBITORS OF 11-BETA-HSD1 | |
RU2502730C2 (ru) | Сульфонамидные соединения и их применение | |
AR049438A1 (es) | Derivados con estructura aroil-o-piperidina, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden y sus aplicaciones terapeuticas | |
AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
AR052898A1 (es) | Derivados de la n-[(4,5-difenil -2-tienil) metil] amina, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para enfermedades mediadas por los receptores canabinoides cb1 | |
SE0201937D0 (sv) | Therapeutic agents | |
DE602004029355D1 (de) | Sulfopyrrolderivate | |
SE0300092D0 (sv) | Novel compounds | |
SE0300091D0 (sv) | Novel compounds | |
DK1970372T3 (da) | Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler | |
UY28688A1 (es) | Derivados de amida | |
RU2008152764A (ru) | Биарилкарбоксиариламиды как модуляторы ванилоидного рецептора типа 1 | |
EA201000084A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
SE0600134L (sv) | Nya föreningar och användning därav | |
RU2008139078A (ru) | Производные сульфонил-3-гетероциклилиндазола в качестве лигандов 5-гидрокситриптамина-6 | |
ATE494281T1 (de) | Ppar-aktivierende verbindung und diese enthaltende pharmazeutische zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |